Sirolimus Solution
Product Images NDC 72162-2641

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Sirolimus (NDC 72162-2641). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (Lbl721622641)

Label (Lbl721622641)
This text provides details on Sirolimus oral solution, including its ingredients such as sirolimus, ethanol, propylene glycol, phosphatidylcholine, and polysorbate 80. It also mentions important information like dosage instructions, prescribing details, storage conditions (refrigerated at 2°C to 8°C), and the manufacturer's details. Sirolimus is used for specific medical purposes and should be used orally within one month after opening.*
FDA Label Image

Sirolimus-fig-1 (Sirolimus Fig 1)

FDA Label Image

Sirolimus-instruction-fig-1 (Sirolimus Instruction Fig 1)

FDA Label Image

Sirolimus-instruction-fig-2 (Sirolimus Instruction Fig 2)

FDA Label Image

Sirolimus-instruction-fig-3 (Sirolimus Instruction Fig 3)

FDA Label Image

Sirolimus-instruction-fig-4 (Sirolimus Instruction Fig 4)

FDA Label Image

Sirolimus-instruction-fig-5 (Sirolimus Instruction Fig 5)

FDA Label Image

Sirolimus-instructions-fig-6 (Sirolimus Instruction Fig 6)

FDA Label Image

Sirolimus-instruction-fig-7 (Sirolimus Instruction Fig 7)

FDA Label Image

Sirolimus-instruction-fig (Sirolimus Instruction Fig)

FDA Label Image

Sirolimus-structure (Sirolimus Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.